Table 2.
Groups | Blood glucose Level (mg/dl) |
% BGL increment |
|||
---|---|---|---|---|---|
0 min | 30 min | 60 min | 120 min | at 30 min | |
NC | 94.40 ± 3.93 | 249.80 ± 34.63 | 209.45 ± 34.95 | 123.20 ± 15.72 | 164.60 |
GL5 | 96.20 ± 6.38 | 110.60 ± 18.85 Aa | 72.40 ± 9.24 Ac | 56.80 ± 3.02 Ac | 15.00 |
RELE100 | 90.40 ± 8.31 | 166.8 ± 12.35 | 119.80 ± 8.57Aa | 89.80 ± 5.03 | 84.50 |
RELE200 | 84.80 ± 6.41 | 137.40 ± 9.76 | 103.80 ± 3.69 Ab | 70.20 ± 3.07 Ab | 62.02 |
RELE400 | 90.00 ± 2.30 | 170.00 ± 12.41 | 109 ± 10.39a2 | 81.00 ± 9.76 Ab | 88.80 |
Note: Each value represents mean ± S.E.M; n = 6; Analysis was performed by one way ANOVA; Acompared to negative control; number followed by RELE and GL indicates dose in mg/kg; ap < 0.05; bp < 0.01; cp < 0.001. Time refers after glucose loading.
Abbreviations: NC, negative control; GL, glibenclamide; RELE, Rubus erlangeri leaf extract.